Quick Answer
UTAH MEDICAL PRODUCTS INC reported Stockholders Equity of $119.27 million for fiscal year 2025.
UTAH MEDICAL PRODUCTS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $119.27M | +1.6% |
| 2024 | $117.43M | -8.5% |
| 2023 | $128.31M | +12.3% |
| 2022 | $114.25M | +6.6% |
| 2021 | $107.14M | +4.2% |
| 2020 | $102.82M | +1.7% |
| 2019 | $101.09M | +13.6% |
| 2018 | $88.99M | +13.9% |
| 2017 | $78.12M | +12.8% |
| 2016 | $69.24M | -0.6% |
| 2015 | $69.65M | +7.9% |
| 2014 | $64.56M | +6.6% |
| 2013 | $60.58M | +18.9% |
| 2012 | $50.97M | +25.1% |
| 2011 | $40.76M | +7.8% |
| 2010 | $37.79M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $118.25M | -4.8% | +0.6% |
| June 30, 2025 | $117.53M | -5.3% | +0.4% |
| March 31, 2025 | $117.05M | -8.4% | -0.3% |
| December 31, 2024 | $117.43M | -8.5% | -5.5% |
| September 30, 2024 | $124.20M | +0.4% | +0.1% |
| June 30, 2024 | $124.05M | +1.9% | -2.9% |
| March 31, 2024 | $127.74M | +8.2% | -0.4% |
| December 31, 2023 | $128.31M | +12.3% | +3.7% |
- UTAH MEDICAL PRODUCTS INC showed an increase of +1.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, UTAH MEDICAL PRODUCTS INC’s stockholders equity has grown by 215.6% (from $37.79 million to $119.27 million).
- The most recent figure is from UTAH MEDICAL PRODUCTS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: